sopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria

Vaccine

Volumn 27, Issue 21, 2009, Pages 2804-2811

  Nagarajan, Arvindhan G ^a   Balasundaram, Sudhagar V ^a   Janice, Jessin ^a   Karnam, Guruswamy ^a   Eswarappa, Sandeepa M ^a   Chakravortty, Dipshikha ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

DNA vaccine; Salmonella; SopB

Indexed keywords

DNA VACCINE; EPITOPE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE ANTIGEN; PLACEBO; SIFB DNA VACCINE; SOPB DNA VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CONJUGATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA VECTOR; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN SECRETION; SALMONELLA ENTERICA; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SCORING SYSTEM; SEROTYPE; VACCINATION;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMPUTATIONAL BIOLOGY; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON-GAMMA; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SPLEEN; VACCINES, ATTENUATED; VACCINES, DNA;

EID: 64449087968     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.092     Document Type: Article

References (43)

1. Ryan K.J., and Ray C.G. Sherris medical microbiology. 4th ed. (2004), McGraw Hill, New York
2. Chan K., Baker S., Kim C.C., Detweiler C.S., Dougan G., and Falkow S. Genomic comparison of Salmonella enterica serovars and Salmonella bongori by use of an S. enterica serovar typhimurium DNA microarray. J Bacteriol 185 2 (2003) 553-563
3. Porwollik S., and McClelland M. Lateral gene transfer in Salmonella. Microbes Infect 5 11 (2003) 977-989
4. Synder JW, Check W. Bioterrorism threats to our future. American Society of Microbiology; 2000.
5. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever: World Health Organ; 2004.
6. Bhan M.K., Bahl R., and Bhatnagar S. Typhoid and paratyphoid fever. Lancet 366 9487 (2005) 749-762
7. Sztein M.B. Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica serovar Typhi strains used as live oral vaccines in humans. Clin Infect Dis 45 Suppl. 1 (2007) S15-S19
8. McKenna A.J., Bygraves J.A., Maiden M.C., and Feavers I.M. Attenuated typhoid vaccine Salmonella typhi Ty21a: fingerprinting and quality control. Microbiology 141 Pt 8 (1995) 1993-2002
9. Fraser A., Paul M., Goldberg E., Acosta C.J., and Leibovici L. Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials. Vaccine 25 45 (2007) 7848-7857
10. Gurunathan S., Klinman D.M., and Seder R.A. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 18 (2000) 927-974
11. Salerno-Goncalves R., Pasetti M.F., and Sztein M.B. Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J Immunol 169 4 (2002) 2196-2203
12. Salerno-Goncalves R., Wyant T.L., Pasetti M.F., Fernandez-Vina M., Tacket C.O., Levine M.M., et al. Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA. J Immunol 170 5 (2003) 2734-2741
13. Sztein M.B., Wasserman S.S., Tacket C.O., Edelman R., Hone D., Lindberg A.A., et al. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis 170 6 (1994) 1508-1517
14. Salerno-Goncalves R., Fernandez-Vina M., Lewinsohn D.M., and Sztein M.B. Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J Immunol 173 9 (2004) 5852-5862
15. Salerno-Goncalves R., Wahid R., and Sztein M.B. Immunization of volunteers with Salmonella enterica serovar Typhi strain Ty21a elicits the oligoclonal expansion of CD8+ T cells with predominant Vbeta repertoires. Infect Immun 73 6 (2005) 3521-3530
16. Pasetti M.F., Salerno-Goncalves R., and Sztein M.B. Salmonella enterica serovar Typhi live vector vaccines delivered intranasally elicit regional and systemic specific CD8+ major histocompatibility class I-restricted cytotoxic T lymphocytes. Infect Immun 70 8 (2002) 4009-4018
17. Lo W.F., Ong H., Metcalf E.S., and Soloski M.J. T cell responses to Gram-negative intracellular bacterial pathogens: a role for CD8+ T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J Immunol 162 9 (1999) 5398-5406
18. Lo W.F., Woods A.S., DeCloux A., Cotter R.J., Metcalf E.S., and Soloski M.J. Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Nat Med 6 2 (2000) 215-218
19. Diaz-Quinonez A., Martin-Orozco N., Isibasi A., and Ortiz-Navarrete V. Two Salmonella OmpC K(b)-restricted epitopes for CD8+-T-cell recognition. Infect Immun 72 5 (2004) 3059-3062
20. Lundin B.S., Johansson C., and Svennerholm A.M. Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans. Infect Immun 70 10 (2002) 5622-5627
21. Mittrucker H.W., Raupach B., Kohler A., and Kaufmann S.H. Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection. J Immunol 164 4 (2000) 1648-1652
22. Mastroeni P., Simmons C., Fowler R., Hormaeche C.E., and Dougan G. Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect Immun 68 1 (2000) 46-53
23. Ravindran R., and McSorley S.J. Tracking the dynamics of T-cell activation in response to Salmonella infection. Immunology 114 4 (2005) 450-458
24. Daugelat S., Ladel C.H., Schoel B., and Kaufmann S.H. Antigen-specific T-cell responses during primary and secondary Listeria monocytogenes infection. Infect Immun 62 5 (1994) 1881-1888
25. Hess J., Gentschev I., Miko D., Welzel M., Ladel C., Goebel W., et al. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc Natl Acad Sci USA 93 4 (1996) 1458-1463
26. Marcus S.L., Knodler L.A., and Finlay B.B. Salmonella enterica serovar Typhimurium effector SigD/SopB is membrane-associated and ubiquitinated inside host cells. Cell Microbiol 4 7 (2002) 435-446
27. Kubori T., and Galan J.E. Temporal regulation of Salmonella virulence effector function by proteosome-dependent protein degradation. Cell 115 3 (2003) 333-342
28. Negi V.D., Singhamahapatra S., and Chakravortty D. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model. Vaccine 25 29 (2007) 5315-5323
29. Parker K.C., Bednarek M.A., and Coligan J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152 1 (1994) 163-175
30. Rammensee H., Bachmann J., Emmerich N.P., Bachor O.A., and Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50 3-4 (1999) 213-219
31. Scheiblhofer S., Chen D., Weiss R., Khan F., Mostbock S., Fegeding K., et al. Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improves protection against malaria infection. Eur J Immunol 31 3 (2001) 692-698
32. Collier-Hyams L.S., Zeng H., Sun J., Tomlinson A.D., Bao Z.Q., Chen H., et al. Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. J Immunol 169 6 (2002) 2846-2850
33. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75 2 (2004) 163-189
34. Locksley R.M., Killeen N., and Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 4 (2001) 487-501
35. Eriksson S., Lucchini S., Thompson A., Rhen M., and Hinton J.C. Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica. Mol Microbiol 47 1 (2003) 103-118
36. Musson J.A., Hayward R.D., Delvig A.A., Hormaeche C.E., Koronakis V., and Robinson J.H. Processing of viable Salmonella typhimurium for presentation of a CD4 T cell epitope from the Salmonella invasion protein C (SipC). Eur J Immunol 32 9 (2002) 2664-2671
37. McSorley S.J., Cookson B.T., and Jenkins M.K. Characterization of CD4+ T cell responses during natural infection with Salmonella typhimurium. J Immunol 164 2 (2000) 986-993
38. Norris F.A., Wilson M.P., Wallis T.S., Galyov E.E., and Majerus P.W. SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase. Proc Natl Acad Sci USA 95 24 (1998) 14057-14059
39. Kuijl C., Savage N.D., Marsman M., Tuin A.W., Janssen L., Egan D.A., et al. Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature 450 7170 (2007) 725-730
40. Lasaro M.O., Alves A.M., Guillobel H.C., Almeida D.F., and Ferreira L.C. New vaccine strategies against enterotoxigenic Escherichia coli. II: Enhanced systemic and secreted antibody responses against the CFA/I fimbriae by priming with DNA and boosting with a live recombinant Salmonella vaccine. Braz J Med Biol Res 32 2 (1999) 241-246
41. Biswas S., Reddy G.S., Srinivasan V.A., and Rangarajan P.N. Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine. Hum Gene Ther 12 15 (2001) 1917-1922
42. Amara R.R., Villinger F., Altman J.D., Lydy S.L., O'Neil S.P., Staprans S.I., et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Vaccine 20 15 (2002) 1949-1955
43. Moore A.C., and Hill A.V. Progress in DNA-based heterologous prime-boost immunization strategies for malaria. Immunol Rev 199 (2004) 126-143